Edwards Lifesciences Corporation
EW
$83.39
$0.951.15%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.36% | 8.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.36% | 8.46% | |||
| Cost of Revenue | 0.23% | 14.19% | |||
| Gross Profit | 1.69% | 6.90% | |||
| SG&A Expenses | 2.51% | 7.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 41.31% | -11.52% | |||
| Total Operating Expenses | 2.42% | 9.82% | |||
| Operating Income | -1.35% | 5.12% | |||
| Income Before Tax | -12.94% | -7.77% | |||
| Income Tax Expenses | -12.75% | -8.53% | |||
| Earnings from Continuing Operations | -12.98% | -7.62% | |||
| Earnings from Discontinued Operations | 54.55% | 38.89% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -52.94% | 6.25% | |||
| Net Income | -12.64% | -6.93% | |||
| EBIT | -1.35% | 5.12% | |||
| EBITDA | -1.00% | 5.04% | |||
| EPS Basic | -12.28% | -6.95% | |||
| Normalized Basic EPS | 10.89% | -7.15% | |||
| EPS Diluted | -11.72% | -7.45% | |||
| Normalized Diluted EPS | 10.86% | -7.14% | |||
| Average Basic Shares Outstanding | -0.39% | 0.02% | |||
| Average Diluted Shares Outstanding | -0.37% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||